Skip to main content

Posts

Showing posts with the label health tech

Featured Post

Market Daily Report: Selective Buying Of Defensive Stocks Lifts Bursa Malaysia Higher At Close

 KUALA LUMPUR, July 29 (Bernama) -- Bursa Malaysia rebounded to close higher on Wednesday on selective buying of defensive stocks after a volatile trading session. IPPFA Sdn Bhd director of investment strategy and country economist Mohd Sedek Jantan said consumer products and services stocks lifted the key index higher, overcoming lingering geopolitical concerns. At 5 pm, the FTSE Bursa Malaysia KLCI (FBM KLCI) rose 3.08 points to 1,715.56 from yesterday’s close of 1,712.48. The benchmark index, which opened 1.91 points higher at 1,714.39, moved between 1,710.79 and 1,720.59 during the day’s trading. In the broader market, gainers outstripped decliners 550 to 476, while 612 counters were unchanged, 1,129 untraded, and 48 suspended. Turnover rose to 2.96 billion units valued at RM2.48 billion from 2.94 billion units valued at RM2.56 billion on Tuesday.

Cathie Wood Doubles Down on Tempus AI as Shares Surge Over 76% YTD

Tempus AI Inc. (NASDAQ: TEM)  continues to draw strong interest from institutional investors, with  Cathie Wood’s ARK Invest  adding to its position in the precision health tech company. In its latest move,  ARK Investment Management purchased 150,563 shares , valued at approximately  US$8.8 million . The majority were acquired through the flagship  ARK Innovation ETF (ARKK) , with a smaller tranche via the  ARK Genomic Revolution ETF (ARKG)  — signaling continued conviction in Tempus’ AI-driven healthcare model. A separate  US$1 million worth of shares  was also added, highlighting ARK's sustained bullish stance. Strategic Expansion in Cancer Detection Tempus has recently  expanded its collaboration with Personalis Inc.  to include  colorectal cancer , alongside existing work in  breast ,  lung , and  immunotherapy monitoring . This bolsters the commercialization of the  NeXT Personal™ MRD (Minimal Res...